Loss of nonphosphorylated neurofilament immunoreactivity in temporal cortical areas in Alzheimer's disease

Neuroscience - Tập 160 Số 2 - Trang 427-433 - 2009
Ramasamy Thangavel1, Shailendra K. Sahu1,2, Gary W. Van Hoesen3,1, Asgar Zaheer1,4
1Department of Neurology, University of Iowa College of Medicine, 200 Hawkins Drive, Iowa City, Iowa 52242, USA
2Department of Neurosurgery, University of Iowa College of Medicine, 200 Hawkins Drive, Iowa City, Iowa 52242, USA
3Department of Anatomy and Cell Biology, University of Iowa College of Medicine, Bowen Science Building, 51 Newton Road, Iowa City, Iowa 52242, USA
4Veterans Affairs Medical Center, Iowa City, Iowa 52242 USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Arnold, 1991, The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease, Cereb Cortex, 1, 103, 10.1093/cercor/1.1.103

Arnold, 1991, Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia, Arch Gen Psychiatry, 48, 625, 10.1001/archpsyc.1991.01810310043008

Arriagada, 1992, Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease, Neurology, 42, 631, 10.1212/WNL.42.3.631

Augustinack, 2002, Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease, Acta Neuropathol, 103, 26, 10.1007/s004010100423

Ayala-Grosso, 2006, Caspase-3 cleaved spectrin colocalizes with neurofilament-immunoreactive neurons in Alzheimer's disease, Neuroscience, 141, 863, 10.1016/j.neuroscience.2006.04.041

Bierer, 1995, Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease, Arch Neurol, 52, 81, 10.1001/archneur.1995.00540250089017

Bobinski, 1997, Relationships between regional neuronal loss and neurofibrillary changes in the hippocampal formation and duration and severity of Alzheimer disease, J Neuropathol Exp Neurol, 56, 414, 10.1097/00005072-199704000-00010

Bouras, 1993, Neurofibrillary tangle densities in the hippocampal formation in a nondemented population define subgroups of patients with differential early pathologic changes, Neurosci Lett, 153, 131, 10.1016/0304-3940(93)90305-5

Bussiere, 2003, Progressive degeneration of nonphosphorylated neurofilament protein-enriched pyramidal neurons predicts cognitive impairment in Alzheimer's disease: stereologic analysis of prefrontal cortex area 9, J Comp Neurol, 463, 281, 10.1002/cne.10760

Bussiere, 2003, Stereologic analysis of neurofibrillary tangle formation in prefrontal cortex area 9 in aging and Alzheimer's disease, Neuroscience, 117, 577, 10.1016/S0306-4522(02)00942-9

Campbell, 1989, Monoclonal antibody to neurofilament protein (SMI-32) labels a subpopulation of pyramidal neurons in the human and monkey neocortex, J Comp Neurol, 282, 191, 10.1002/cne.902820204

Duong, 1994, Immunoreactivity patterns in neurofibrillary tangles of the inferior temporal cortex in Alzheimer disease, Mol Chem Neuropathol, 22, 105, 10.1007/BF03160099

Elston, 1997, The occipitoparietal pathway of the macaque monkey: comparison of pyramidal cell morphology in layer III of functionally related cortical visual areas, Cereb Cortex, 7, 432, 10.1093/cercor/7.5.432

Fukutani, 2000, Neuronal loss and neurofibrillary degeneration in the hippocampal cortex in late-onset sporadic Alzheimer's disease, Psychiatry Clin Neurosci, 54, 523, 10.1046/j.1440-1819.2000.00747.x

Giannakopoulos, 2003, Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease, Neurology, 60, 1495, 10.1212/01.WNL.0000063311.58879.01

Gomez-Isla, 1997, Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease, Ann Neurol, 41, 17, 10.1002/ana.410410106

Gomez-Isla, 1996, Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease, J Neurosci, 16, 4491, 10.1523/JNEUROSCI.16-14-04491.1996

Guillozet, 2003, Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment, Arch Neurol, 60, 729, 10.1001/archneur.60.5.729

Hof, 1990, Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I, J Comp Neurol, 301, 44, 10.1002/cne.903010105

Hof, 1990, Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: II, J Comp Neurol, 301, 55, 10.1002/cne.903010106

Hof, 1995, Neurofilament protein defines regional patterns of cortical organization in the macaque monkey visual system: a quantitative immunohistochemical analysis, J Comp Neurol, 352, 161, 10.1002/cne.903520202

Hof, 1996, Distribution of neurofilament protein and calcium-binding proteins parvalbumin, calbindin, and calretinin in the canine hippocampus, J Chem Neuroanatomy, 11, 1, 10.1016/0891-0618(96)00117-2

Hof, 1996, Neurofilament protein is differentially distributed in subpopulations of corticocortical projection neurons in the macaque monkey visual pathways, J Comp Neurol, 376, 112, 10.1002/(SICI)1096-9861(19961202)376:1<112::AID-CNE7>3.0.CO;2-6

Law, 2003, The distribution and morphology of prefrontal cortex pyramidal neurons identified using anti-neurofilament antibodies SMI32, N200 and FNP7, J Psychiatr Res, 37, 487, 10.1016/S0022-3956(03)00075-X

Lewis, 1987, Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices, J Neurosci, 7, 1799, 10.1523/JNEUROSCI.07-06-01799.1987

Macdonald, 2002, Pyramidal cell loss in motor cortices in Huntington's disease, Neurobiol Dis, 10, 378, 10.1006/nbdi.2002.0528

Mitchell, 2002, Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease, Ann Neurol, 51, 182, 10.1002/ana.10086

Morrison, 2002, Selective vulnerability of corticocortical and hippocampal circuits in aging and Alzheimer's disease, Prog Brain Res, 136, 467, 10.1016/S0079-6123(02)36039-4

Morrison, 1987, A monoclonal antibody to nonphosphorylated neurofilament protein marks the vulnerable cortical neurons in Alzheimer's disease, Brain Res, 416, 331, 10.1016/0006-8993(87)90914-0

Radenahmad, 2003, A neurofilament antibody recognizes a subset of pyramidal cells in the human neocortex that are preserved in Alzheimer's disease, Neuropathol Appl Neurobiol, 29, 316, 10.1046/j.1365-2990.2003.00460.x

Shepherd, 2001, Neurofilament-immunoreactive neurons are not selectively vulnerable in Alzheimer's disease, Neurobiol Dis, 8, 136, 10.1006/nbdi.2000.0361

Sieradzan, 2001, The selective vulnerability of nerve cells in Huntington's disease, Neuropathol Appl Neurobiol, 27, 1, 10.1046/j.0305-1846.2001.00299.x

Su, 1996, Plaque biogenesis in brain aging and Alzheimer's disease, Brain Res, 739, 79, 10.1016/S0006-8993(96)00811-6

Thangavel, 2008, Modular and laminar pathology of brodmann's area 37 in Alzheimer's disease, Neuroscience, 152, 50, 10.1016/j.neuroscience.2007.12.025

Thangavel, 2009, The abnormally phosphorylated tau lesion of early Alzheimer's disease, Neurochem Res, 34, 118, 10.1007/s11064-008-9701-1

Vickers, 1994, Alterations in neurofilament protein immunoreactivity in human hippocampal neurons related to normal aging and Alzheimer's disease, Neuroscience, 62, 1, 10.1016/0306-4522(94)90310-7

Wakabayashi, 1995, Cortical Lewy body-containing neurons are pyramidal cells: laser confocal imaging of double-immunolabeled sections with antiubiquitin and SMI32, Acta Neuropathol, 89, 404, 10.1007/BF00307643